The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic Cystic Fibrosis Patients

NCT02496780 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: novolog insulin
DRUG: levemir insulin
DRUG: placebo

Sponsor

University of Minnesota